Our top story in this week’s Cannabis Report centres on Curaleaf (TSX:CURA), which continues to tout the value it would bring to Aurora Cannabis shareholders, should they agree to a proposed acquisition, recently releasing a fact sheet addressing why the combined company would be preferrable to continuing to exist as separate entities.
Key points of contention covered in the fact sheet include the size of the offer premium compared to Aurora’s current stock price, the stark difference in the companies’ level of insider ownership, as well as the perceived dangers of Curaleaf’s extensive US exposure.
Click here for the full story.
Top cannabis news stories
1 | Aurora Cannabis (TSX/NASDAQ:ACB), meanwhile, has remained adamant about the unsuitability of Curaleaf’s acquisition terms, focusing instead on capitalizing on its moment in the spotlight to ramp up its flagship medical cannabis business with a new strategic hire, whose 25 years of global biopharmaceutical experience specializing in product strategy and commercial transformations is sparking enthusiasm about the company’s near-term future.
2 | Cannabix Technologies (CSE:BLO) has been fostering shareholder value as of late through consistent deployments of its BreathLogix alcohol monitoring solution, a complement to its Marijuana Breath Test device, most recently at the Lake County Community Corrections Program in Indiana, where the technology will support court-ordered alcohol monitoring compliance.
3 | Jushi Holdings (CSE:JUSH) offered the market a green flag in the form of Founder, Chairman and Chief Executive Officer, Jim Cacioppo, purchasing 2,019,798 shares of company stock in the open market for total consideration of C$1,010,000. His investment follows Jushi’s promising second quarter, which saw the company cut its losses by more than 40 per cent.
4 | Finally, Cannara Biotech (TSX:LOVE) expanded its credit agreement with TD Bank and Bank of Montreal to C$80 million, up from C$50 million, highlighting the Canadian market as a reliable source of capital for high-quality cannabis companies. Cannara posted record revenue in Q3 while growing net income.
Top cannabis stocks Sept. 4 to Sept. 11, 2026
- T.CURA | 7,400 views | Curaleaf Holdings Inc.
- T.ACB | 2,900 views | Aurora Cannabis Inc.
- T.LABS | 1,700 views | Medipharm Labs Corp.
- T.TLRY | 1,700 views | Tilray Brands Inc.
- T.OGI | 607 views | Organigram Global Inc.
- C.BLO | 490 views | Cannabix Technolgies Inc.
Join the discussion: Find out what investors are saying about cannabis stocks and this week’s Cannabis Report on Stockhouse’s stock forums and message boards.
